Editorial Board Member - JCS
Suling Liu
ProfessorSchool of Life Sciences
University of Science & Technology
China
RESEARCH INTERESTS:
- Identifying different states of breast stem cells to develop the novel combination therapies targeting different breast cancer stem cells.
- Investigating the combination therapy of PARPi and 17-AAG to target cancer stem cells in Triple-negative breast cancers.
- Studying the effects of microRNAs on breast cancer stem cell self-renewal and differentiation, and develop some miRNA-based therapies with nanotechnology.
- Studying the tumor microenvironment in regulating breast cancer stem cells
Other Editorial Board Members - JCS
Peter Lobie
Principal Investigator
Cancer Science Institute of Singapore
National University of Singapore
Singapore
Cancer Science Institute of Singapore
National University of Singapore
Singapore
Dagmara McGuinness
Research Associate
College of Medical
Veterinary & Life Sciences
Institute of Cancer Sciences
Western Infirmary Glasgow
Scotland
College of Medical
Veterinary & Life Sciences
Institute of Cancer Sciences
Western Infirmary Glasgow
Scotland
XIAOYANG QI
Associate Director
Division of Hematology-Oncology
Department of Internal Medicine
University of Cincinnati
United States
Division of Hematology-Oncology
Department of Internal Medicine
University of Cincinnati
United States
Chunying Li
Assistant Professor
Department of Biochemistry and Molecular Biology
Wayne State University School of Medicine
United States
Department of Biochemistry and Molecular Biology
Wayne State University School of Medicine
United States
Lili Chen
Associate Professor
Department of Radiation Oncology
Fox Chase Cancer Center
United States
Department of Radiation Oncology
Fox Chase Cancer Center
United States
Nagendra K. Prasad
Assistant Professor
Division of Hematology and Oncology
Indiana University School of Medicine
United States
Division of Hematology and Oncology
Indiana University School of Medicine
United States
